Los puntos clave no están disponibles para este artículo en este momento.
Cholesterol efflux capacity, a new biomarker that characterizes a key step in reverse cholesterol transport, was inversely associated with the incidence of cardiovascular events in a population-based cohort. (Funded by the Donald W. Reynolds Foundation and others.).
Rohatgi et al. (Tue,) studied this question.